195 related articles for article (PubMed ID: 29121805)
1. Prostate Cancer Xenograft Inhibitory Activity and Pharmacokinetics of Decursinol, a Metabolite of Angelica gigas Pyranocoumarins, in Mouse Models.
Wu W; Tang SN; Zhang Y; Puppala M; Cooper TK; Xing C; Jiang C; Lü J
Am J Chin Med; 2017; 45(8):1773-1792. PubMed ID: 29121805
[TBL] [Abstract][Full Text] [Related]
2. In vivo anti-cancer activity of Korean Angelica gigas and its major pyranocoumarin decursin.
Lee HJ; Lee HJ; Lee EO; Lee JH; Lee KS; Kim KH; Kim SH; Lü J
Am J Chin Med; 2009; 37(1):127-42. PubMed ID: 19222117
[TBL] [Abstract][Full Text] [Related]
3. Chemopreventive Effects of Korean Angelica versus Its Major Pyranocoumarins on Two Lineages of Transgenic Adenocarcinoma of Mouse Prostate Carcinogenesis.
Tang SN; Zhang J; Wu W; Jiang P; Puppala M; Zhang Y; Xing C; Kim SH; Jiang C; Lü J
Cancer Prev Res (Phila); 2015 Sep; 8(9):835-44. PubMed ID: 26116406
[TBL] [Abstract][Full Text] [Related]
4. Pyranocoumarin Tissue Distribution, Plasma Metabolome and Prostate Transcriptome Impacts of Sub-Chronic Exposure to Korean Angelica Supplement in Mice.
Zhang J; Li L; Tang S; Zhang Y; Markiewski M; Xing C; Jiang C; Lü J
Am J Chin Med; 2016; 44(2):321-53. PubMed ID: 27080944
[TBL] [Abstract][Full Text] [Related]
5. Interception Targets of
Tang SN; Jiang P; Kim S; Zhang J; Jiang C; Lü J
Cancer Prev Res (Phila); 2021 Jun; 14(6):635-648. PubMed ID: 33648943
[TBL] [Abstract][Full Text] [Related]
6. Quantitative determination of decursin, decursinol angelate, and decursinol in mouse plasma and tumor tissue using liquid-liquid extraction and HPLC.
Li L; Zhang J; Shaik AA; Zhang Y; Wang L; Xing C; Kim SH; Lü J
Planta Med; 2012 Feb; 78(3):252-9. PubMed ID: 22116603
[TBL] [Abstract][Full Text] [Related]
7. Natural Korean Medicine Dang-Gui: Biosynthesis, Effective Extraction and Formulations of Major Active Pyranocoumarins, Their Molecular Action Mechanism in Cancer, and Other Biological Activities.
Reddy CS; Kim SC; Hur M; Kim YB; Park CG; Lee WM; Jang JK; Koo SC
Molecules; 2017 Dec; 22(12):. PubMed ID: 29215592
[No Abstract] [Full Text] [Related]
8. Single oral dose pharmacokinetics of decursin, decursinol angelate, and decursinol in rats.
Li L; Zhang J; Xing C; Kim SH; Lü J
Planta Med; 2013 Mar; 79(3-4):275-80. PubMed ID: 23364885
[TBL] [Abstract][Full Text] [Related]
9. Anti-cancer and other bioactivities of Korean Angelica gigas Nakai (AGN) and its major pyranocoumarin compounds.
Zhang J; Li L; Jiang C; Xing C; Kim SH; Lü J
Anticancer Agents Med Chem; 2012 Dec; 12(10):1239-54. PubMed ID: 22583405
[TBL] [Abstract][Full Text] [Related]
10. Anti-tumor activities of decursinol angelate and decursin from Angelica gigas.
Lee S; Lee YS; Jung SH; Shin KH; Kim BK; Kang SS
Arch Pharm Res; 2003 Sep; 26(9):727-30. PubMed ID: 14560921
[TBL] [Abstract][Full Text] [Related]
11. Single oral dose pharmacokinetics of decursin and decursinol angelate in healthy adult men and women.
Zhang J; Li L; Hale TW; Chee W; Xing C; Jiang C; Lü J
PLoS One; 2015; 10(2):e0114992. PubMed ID: 25695490
[TBL] [Abstract][Full Text] [Related]
12. A novel class of pyranocoumarin anti-androgen receptor signaling compounds.
Guo J; Jiang C; Wang Z; Lee HJ; Hu H; Malewicz B; Lee HJ; Lee JH; Baek NI; Jeong JH; Kim DK; Kang KS; Kim SH; Lu J
Mol Cancer Ther; 2007 Mar; 6(3):907-17. PubMed ID: 17363485
[TBL] [Abstract][Full Text] [Related]
13. Effects of Angelica gigas Nakai on the production of decursin- and decursinol angelate-enriched eggs.
Fontamillas GAD; Kim SW; Kim HU; Kim SJ; Kim JG; Park TS; Park BC
J Sci Food Agric; 2019 Apr; 99(6):3117-3123. PubMed ID: 30536922
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous Determination of Decursin, Decursinol Angelate, Nodakenin, and Decursinol of
Kim SJ; Ko SM; Choi EJ; Ham SH; Kwon YD; Lee YB; Cho HY
Molecules; 2018 Apr; 23(5):. PubMed ID: 29701699
[TBL] [Abstract][Full Text] [Related]
15. Nanocomposites based on Soluplus and Angelica gigas Nakai extract fabricated by an electrohydrodynamic method for oral administration.
Lee JJ; Nam S; Park JH; Lee SY; Jeong JY; Lee JY; Kang WS; Yoon IS; Kim DD; Cho HJ
J Colloid Interface Sci; 2016 Dec; 484():146-154. PubMed ID: 27599383
[TBL] [Abstract][Full Text] [Related]
16.
Lü J; Jiang C; Schell TD; Joshi M; Raman JD; Xing C
Am J Chin Med; 2022; 50(6):1475-1527. PubMed ID: 35876033
[No Abstract] [Full Text] [Related]
17. A synthetic decursin analog with increased in vivo stability suppresses androgen receptor signaling in vitro and in vivo.
Zhang Y; Shaik AA; Xing C; Chai Y; Li L; Zhang J; Zhang W; Kim SH; Lü J; Jiang C
Invest New Drugs; 2012 Oct; 30(5):1820-9. PubMed ID: 21870073
[TBL] [Abstract][Full Text] [Related]
18. Cytochrome P450 Isoforms in the Metabolism of Decursin and Decursinol Angelate from Korean Angelica.
Zhang J; Li L; Tang S; Hale TW; Xing C; Jiang C; Lü J
Am J Chin Med; 2015; 43(6):1211-30. PubMed ID: 26394652
[TBL] [Abstract][Full Text] [Related]
19. In vitro metabolism of pyranocoumarin isomers decursin and decursinol angelate by liver microsomes from man and rodents.
Li L; Zhang J; Xing C; Kim SH; Jiang C; Lü J
Planta Med; 2013 Nov; 79(16):1536-44. PubMed ID: 24026903
[TBL] [Abstract][Full Text] [Related]
20. Potent antiandrogen and androgen receptor activities of an Angelica gigas-containing herbal formulation: identification of decursin as a novel and active compound with implications for prevention and treatment of prostate cancer.
Jiang C; Lee HJ; Li GX; Guo J; Malewicz B; Zhao Y; Lee EO; Lee HJ; Lee JH; Kim MS; Kim SH; Lu J
Cancer Res; 2006 Jan; 66(1):453-63. PubMed ID: 16397261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
